Onconova Therapeutics Inc - Warrants (01/08/2021)
ONTXW
Get informed when a big investor buys or sells
+ FollowMarket Cap$507.36M
Close$
Share Statistics
| Market cap | $507.36 Million |
|---|---|
| Enterprise Value | $504.23 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.83 |
| Beta | 4.07 |
| Outstanding Shares | 10,640,625 |
Return
| Return on Equity | -172367.12% |
|---|---|
| Return on Assets | 112241.52% |
| Return on Invested Capital | 435.53% |
Valuation & Multiples
| P/E Ratio | -0.87 |
|---|---|
| PEG | 5.41 |
| Price to Sales | - |
| Price to Book Ratio | -0.07 |
| Enterprise Value to Revenue | 177.11 |
| Enterprise Value to EBIT | -22.92 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Onconova Therapeutics Inc
CEO: Steven Fruchtman